Search | TVST | ARVO Journals

Showing 1 – 20 of 22

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Autoinflammation and Autoimmunity in the Aqueous Humor of Glaucoma Patients

Eitan Katz; Yang Yang; Christian Kim; Bayasgalan Surenkhuu; Azza Dammak; Vidhya R Rao; Christine Mun; Anubhav Pradeep; Ahmad A Aref; Pooja Bhat; Jose de la Cruz; Simon Kaja; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):575.

ARVO Annual Meeting Abstract June 2024

Safety and Efficacy of Deoxyribonuclease I (DNase) Eye Drops for Ocular Graft vs Host Disease (oGVHD)

Christian Kim; Bayasgalan Surenkhuu; Monazzah Sarwar; Tanya Sheth; Christine Mun; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2969.

ARVO Annual Meeting Abstract June 2024

Chronic Ocular GVHD (oGVHD) may be the Sole Organ Manifestation After Allogeneic Hematopoietic Stem Cell Transplant (HSCT)

Tanya Sheth; Bayasgalan Surenkhuu; Christian Kim; Alexandria Bernal; Monazzah Sarwar; Christine Mun; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2943.

ARVO Annual Meeting Abstract June 2024

‘Window of Opportunity’ in Ocular Graft-versus-Host Disease (oGVHD) Treatment

Christine Mun; Tanya Sheth; Bayasgalan Surenkhuu; Christian Kim; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2942.

ARVO Annual Meeting Abstract June 2023

HLA DRB1 Tissue Typing Shows Antigen HLA DRB1*04 as a Possible Predictor of Dry Eye Disease (DED)

Priyanka Dondeti; Bayasgalan Surenkhuu; Alexandria Bernal; Tanya Sheth; Christian Kim; Jessica Mun; Diana Hernandez Castro; Annette Garcia; Anubhav Pradeep; Gvozdjan Kristina; Sujata Gaitonde; Christine Mun; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3981.

ARVO Annual Meeting Abstract June 2023

Corneal Epithelial Thickness in Dry Eye Disease (DED) Patients: Association with Autoimmunity

Alexandria Bernal; Yang Yang; Bayasgalan Surenkhuu; Jessica Mun; Annette Garcia; Diana Hernandez Castro; Anubhav Pradeep; Tanya Sheth; Christian Kim; Ping-Shou Zhong; Christine Mun; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3977.

ARVO Annual Meeting Abstract June 2022

In Vivo Confocal Microscopy Reveals Cellular and Structural Abnormalities in Patients with Definite Ocular Graft-vs-Host Disease (oGVHD)

Tanya Sheth; Bayasgalan Surenkhuu; Jessie Mun; Annette Garcia; Diana Hernandez-Castro; Anubhav Pradeep; Christine Mun; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1533 – A0258.

ARVO Annual Meeting Abstract June 2021

Combinatorial Therapy with Immunosuppressive, Immunomodulatory and Tear Substitute Eyedrops (‘Triple Play’) in Recalcitrant Immunological Ocular Surface Diseases

Sarah Sunshine; Eitan Katz; Christine Mun; Jessica Mun; Caitlin Berek; Anubhav Pradeep; Bayasgalan Surenkhuu; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1306.

ARVO Annual Meeting Abstract June 2021

Recombinant Deoxyribonuclease I (DNase) Eye Drops for Ocular Graft vs Hosts Disease (oGVHD): Results of a Randomized Clinical Trial

Bayasgalan Surenkhuu; Christine Mun; Nour Atassi; Nikhil Dhall; Jessica Mun; Caitlin Berek; Christian Kim; Monazzah Akbar Sarwar; Anubhav Pradeep; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1276.

ARVO Annual Meeting Abstract June 2021

Ocular Graft vs Hosts Disease (oGVHD) After Allogenic Hematopoietic Stem Cell Transplant (allo-HSCT): A 2 Year Longitudinal, Observational Study

Nour Atassi; Bayasgalan Surenkhuu; Jessica Mun; Caitlin Berek; Anna Ahn; Nikhil Dhall; Christian Kim; Sarah Abdul-Hadi; Anubhav Pradeep; Christine Mun; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1244.

ARVO Annual Meeting Abstract June 2020

Citrullinated protein and Anti-Citrullinated Protein Antibodies (ACPAs) are present in Tear fluid of Dry Eye Disease (DED) patients – Pathophysiological Implications

nikhil dhall; Jieun Kwon; Seungwon An; Jessica Jung Hee Mun; Raju Ilangovan; Bayasgalan Surenkhuu; Caitlin Berek; Christine Mun; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):323.

ARVO Annual Meeting Abstract July 2019

Sub-Anticoagulant Dose Heparin Dismantles Neutrophil Extracellular Traps (NETs): Therapeutic Implementations for Dry Eye Disease (DED)

Jieun Kwon; SEUNGWON AN; Illangovan Raju; Bayasgalan Surenkhuu; Anubhav Pradeep; Christine Mun; Nour Atassi; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):309.

ARVO Annual Meeting Abstract July 2019

Anti-Citrullinated Protein Antibodies (ACPA) are Present in Tear Fluid of Dry Eye Disease (DED) Patients: Diagnostic and Therapeutic Implications

Sandeep Jain; SEUNGWON AN; Jieun Kwon; Bayasgalan Surenkhuu; Illangovan Raju; Nour Atassi; Anubhav Pradeep; Christine Mun

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6786.

ARVO Annual Meeting Abstract July 2019

Recombinant Deoxyribonuclease (DNase) Eye Drops Use in Patients with Dry Eye Disease: Results of a Randomized Clinical Trial

Christine Mun; Sapna Tibrewal; Anna Ahn; Azucena Lopez; Nour Atassi; Bayasgalan Surenkhuu; Morgan Buwick; Hirali Shah; Shivali Shukla; Jessica Mun; Anubhav Pradeep; Illangovan Raju; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6759.

ARVO Annual Meeting Abstract July 2019

LIGHT Protein is a Potential Biomarker for Ocular Graft-VS-Host Disease (oGVHD)

Bayasgalan Surenkhuu; Illangovan Raju; SEUNGWON AN; Jieun Kwon; Anubhav Pradeep; Nour Atassi; Christine Mun; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6764.

ARVO Annual Meeting Abstract July 2019

Superior limbic keratoconjunctivitis: An analysis of clinical and pathophysiological features and therapeutic outcomes

Morgan Buwick; Levi Kanu; Bayasgalan Surenkhuu; Christine Mun; Nour Atassi; Shivali Shukla; Hirali Shah; Jessica Mun; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2774.

Clinical Trials May 2019

A Phase I/II Placebo-Controlled Randomized Pilot Clinical Trial of Recombinant Deoxyribonuclease (DNase) Eye Drops Use in Patients With Dry Eye Disease

PDF

Christine Mun; Shilpa Gulati; Sapna Tibrewal; Yi-Fan Chen; Seungwon An; Bayasgalan Surenkhuu; Ilangovan Raju; Morgan Buwick; Anna Ahn; Ji-Eun Kwon; Nour Atassi; Anubhav Pradeep; Damiano Rondelli; Sandeep Jain
TAGS: deoxyribonucleases, dry eye syndromes, eyedrops, placebos, deoxyribonuclease i
Trans. Vis. Sci. Tech.. 2019; 8(3):10. https://doi.org/10.1167/tvst.8.3.10

ARVO Annual Meeting Abstract July 2018

Neutrophil Extracellular Traps (NETs) in Patients with Dry Eye Disease Secondary to ocular Graft-vs-Host-Disease (oGVHD): Pathological Consequences and Therapeutic Implications

Sandeep Jain; SEUNGWON AN; ILANGOVAN RAJU; Bayasgalan Surenkhuu; Satyabrata Sinha; Damiano Rondelli; Christine Mun

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4873.

ARVO Annual Meeting Abstract July 2018

Oncostatin M (OSM) Contributes to Corneal Epitheliopathy in Tear Deficient Dry Eye Disease due to Chronic ocular Graft-Vs-Host Disease (oGVHD)

Christine Mun; SEUNGWON AN; ILANGOVAN RAJU; Bayasgalan Surenkhuu; Satyabrata Sinha; Pei-Yu Wu; Anubhav Pradeep; Anna Ahn; Jieun Kwon; Azucena Lopez; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3292.

ARVO Annual Meeting Abstract July 2018

Sub-Anticoagulant Dose Heparin is a Potential Therapy for Tear Deficient Dry Eye Disease in patients with ocular Graft-Vs-Host Disease (oGVHD).

SEUNGWON AN; ILANGOVAN RAJU; Bayasgalan Surenkhuu; Satyabrata Sinha; Pei-Yu Wu; Anna Ahn; Anubhav Pradeep; Jieun Kwon; Azucena Lopez; Christine Mun; Sandeep Jain

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3293.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Autoinflammation and Autoimmunity in the Aqueous Humor of Glaucoma Patients

Safety and Efficacy of Deoxyribonuclease I (DNase) Eye Drops for Ocular Graft vs Host Disease (oGVHD)

Chronic Ocular GVHD (oGVHD) may be the Sole Organ Manifestation After Allogeneic Hematopoietic Stem Cell Transplant (HSCT)

‘Window of Opportunity’ in Ocular Graft-versus-Host Disease (oGVHD) Treatment

HLA DRB1 Tissue Typing Shows Antigen HLA DRB1*04 as a Possible Predictor of Dry Eye Disease (DED)

Corneal Epithelial Thickness in Dry Eye Disease (DED) Patients: Association with Autoimmunity

In Vivo Confocal Microscopy Reveals Cellular and Structural Abnormalities in Patients with Definite Ocular Graft-vs-Host Disease (oGVHD)

Combinatorial Therapy with Immunosuppressive, Immunomodulatory and Tear Substitute Eyedrops (‘Triple Play’) in Recalcitrant Immunological Ocular Surface Diseases

Recombinant Deoxyribonuclease I (DNase) Eye Drops for Ocular Graft vs Hosts Disease (oGVHD): Results of a Randomized Clinical Trial

Ocular Graft vs Hosts Disease (oGVHD) After Allogenic Hematopoietic Stem Cell Transplant (allo-HSCT): A 2 Year Longitudinal, Observational Study

Citrullinated protein and Anti-Citrullinated Protein Antibodies (ACPAs) are present in Tear fluid of Dry Eye Disease (DED) patients – Pathophysiological Implications

Sub-Anticoagulant Dose Heparin Dismantles Neutrophil Extracellular Traps (NETs): Therapeutic Implementations for Dry Eye Disease (DED)

Anti-Citrullinated Protein Antibodies (ACPA) are Present in Tear Fluid of Dry Eye Disease (DED) Patients: Diagnostic and Therapeutic Implications

Recombinant Deoxyribonuclease (DNase) Eye Drops Use in Patients with Dry Eye Disease: Results of a Randomized Clinical Trial

LIGHT Protein is a Potential Biomarker for Ocular Graft-VS-Host Disease (oGVHD)

Superior limbic keratoconjunctivitis: An analysis of clinical and pathophysiological features and therapeutic outcomes

A Phase I/II Placebo-Controlled Randomized Pilot Clinical Trial of Recombinant Deoxyribonuclease (DNase) Eye Drops Use in Patients With Dry Eye Disease

Neutrophil Extracellular Traps (NETs) in Patients with Dry Eye Disease Secondary to ocular Graft-vs-Host-Disease (oGVHD): Pathological Consequences and Therapeutic Implications

Oncostatin M (OSM) Contributes to Corneal Epitheliopathy in Tear Deficient Dry Eye Disease due to Chronic ocular Graft-Vs-Host Disease (oGVHD)

Sub-Anticoagulant Dose Heparin is a Potential Therapy for Tear Deficient Dry Eye Disease in patients with ocular Graft-Vs-Host Disease (oGVHD).

To View More...

You must be signed into an individual account to use this feature.